Management
Medications are reviewed as some have side effects that may contribute to fatigue and the interactions of medications are complex.Psychostimulants such as methylphenidate, amphetamines, and modafinil have been used in the treatment of fatigue related to depression, chronic fatigue syndrome, and medical illness such as cancer. They have also been used to counteract fatigue in sleep loss and in aviation. See also
References
Further reading
Byung-Chul Han: Müdigkeitsgesellschaft. Matthes & Seitz, Berlin 2010, ISBN 978-3882216165. (Philosophical essay about fatigue as a sociological problem and symptom). Danish edition: Træthedssamfundet. Møller, 2012, ISBN 978-8799404377. Dutch edition: De vermoeide samenleving. van gennep, 2012, ISBN 978-9461640710. Italian editions : La società della stanchezza. nottetempo, 2012, ISBN 978-8874523450. Korean edition: 한병철 지음 | 김태환 옮김. Moonji, 2011, ISBN 978-8932023960. Spanish edition: La sociedad del cansancio. Herder Editorial, 2012, ISBN 978-8425428685. External links

Fatigue –  Information for Patients, U.S. National Cancer Institute
Europe
The prevalence of congenital corneal opacities (CCO) is estimated to be 3 in 100,000 newborns. This number increases to 6 in 100,000 if congenital glaucoma patients are included. A study of live births in Spain reported that corneal opacities accounted for 3.11% of congenital eye malformations (Bermejo et al, 1998). About 4% of keratoplasties done in the pediatric population in Denmark are due to congenital anomalies (Hovlykke et al, 2014). India
In NPCB survey (2001-2002) Corneal opacity was the 6th major cause of blindness in India, which accounts for 0.9% of total blind population. In the RAAB (Rapid Assessment of Avoidable Blindness) survey (2006-2007) Corneal opacity including Trachoma was mentioned as the second major cause of blindness, which accounts for 6.5% of total blindness. See also
Corneal transplantation
Corneal ulcer
Corneal button


== References ==